Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;29(10):2044-2053.
doi: 10.3201/eid2910.230181.

Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa

Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa

Dikeledi Kekana et al. Emerg Infect Dis. 2023 Oct.

Abstract

Candida auris was first detected at a university-affiliated hospital in Johannesburg, South Africa, in 2009. We used whole-genome sequencing to describe the molecular epidemiology of C. auris in the same hospital during 2016-2020; the neonatal unit had a persistent outbreak beginning in June 2019. Of 287 cases with culture-confirmed C. auris infection identified through laboratory surveillance, 207 (72%) had viable isolates and 188 (66%) were processed for whole-genome sequencing. Clade III (118/188, 63%) and IV (70/188, 37%) isolates co-circulated in the hospital. All 181/188 isolates that had a fluconazole MIC >32 µg/mL had ERG11 mutations; clade III isolates had VF125AL substitutions, and clade IV isolates had K177R/N335S/E343D substitutions. Dominated by clade III, the neonatal unit outbreak accounted for 32% (91/287) of all cases during the study period. The outbreak may have originated through transmission from infected or colonized patients, colonized healthcare workers, or contaminated equipment/environment.

Keywords: Candida auris; South Africa; antifungal resistance; antimicrobial resistance; fungi; genome analysis; population genetics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Epidemic curve by ward location for 287 laboratory-confirmed cases of Candida auris infection or colonization at an academic tertiary hospital, South Africa, March 2016–July 2020. ICU, intensive care unit.
Figure 2
Figure 2
Phylogenetic tree depicting clade distribution and fluconazole resistance mutations of 188 invasive or colonizing South African Candida auris strains isolated from patients admitted to a large metropolitan hospital in South Africa, 2016–2020. The unrooted maximum-parsimony tree was created using MEGA software (https://www.megasoftware.net) using 287,338 single-nucleotide polymorphisms based on 1,000 bootstrap replicates. Scale bar indicates number of pairwise differences. FCZ, fluconazole.
Figure 3
Figure 3
Clade distribution of 188 South African Candida auris isolates from patients admitted to a large metropolitan hospital classified by the patients’ ward locations, South Africa, 2016–2020. ICU, intensive care unit.
Figure 4
Figure 4
Root-to-tip regression analysis of 67 South African Candida auris outbreak isolates from the neonatal ward of a large metropolitan hospital in South Africa. Genetic distance is plotted against sampling time. Every data point represents a tip on the phylogeny. Black line indicates correlation coefficient for the regression. Green lines represent the evolutionary rate in substitutions/site/day.
Figure 5
Figure 5
Maximum clade credibility tree of 118 South Africa clade III Candida auris isolates from patients at an academic tertiary hospital in South Africa estimated using BEAST strict clock and coalescent model (24). Red tips represent cases from the neonatal ward, blue bars represent 95% highest probability density black dashed line indicates clade III tMRCA, and red dashed line indicates outbreak strain tMRCA. tMRCA, time to most recent common ancestor.

References

    1. Spivak ES, Hanson KE. Candida auris: an emerging fungal pathogen. J Clin Microbiol. 2018;56:e01588–17. 10.1128/JCM.01588-17 - DOI - PMC - PubMed
    1. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24. 10.1099/jmm.0.045054-0 - DOI - PubMed
    1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41–4. 10.1111/j.1348-0421.2008.00083.x - DOI - PubMed
    1. Govender NP, Patel J, Magobo RE, Naicker S, Wadula J, Whitelaw A, et al. ; TRAC-South Africa group. Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa. J Antimicrob Chemother. 2016;71:1994–2004. 10.1093/jac/dkw091 - DOI - PMC - PubMed
    1. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134–40. 10.1093/cid/ciw691 - DOI - PMC - PubMed

Publication types

LinkOut - more resources